Evidence map›Paper›PMID 23026132›Full record

SynthesisEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2013

Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.

Stefan Kloiber, Stephan Ripke, Martin A Kohli, Simone Reppermund, Daria Salyakina, Rudolf Uher, Peter McGuffin, Roy H Perlis, Steven P Hamilton, Benno Pütz and 13 more

Open access · greenAbstract readMeta-AnalysisObservational Study
In one paragraph

Synthesis in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Changes in RNA expression levels during antidepressant treatment: a systematic review.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Use of Serum Biomarkers to Aid Antidepressant Selection in Depressive Patients.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  5. Interactive Effects of Serum Leptin Levels and Physical Comorbidity on the Pharmacotherapeutic Response of Depressive Disorders.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  6. A Longitudinal Study of the Association between theInternational journal of molecular sciences · 2022
    Article
  7. Review
  8. Leptin polymorphism rs3828942: risk for anxiety disorders?European archives of psychiatry and clinical neuroscience · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Gut feelings about depression.Journal of psychiatry & neuroscience : JPN · 2014
    Article
  16. Review
  17. Article
  18. Mechanisms of antidepressant resistance.Frontiers in pharmacology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 4 countries.

Stefan KloiberMax-Planck-Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany. stkloiber@mpipsykl.mpg.de
Stephan Ripke
Martin A Kohli
Simone Reppermund
Daria Salyakina
Rudolf Uher
Peter McGuffin
Roy H Perlis
Steven P Hamilton
Benno Pütz
Johannes Hennings
Tanja Brückl
Torsten Klengel
Thomas Bettecken
Marcus Ising
Manfred Uhr
Tatjana Dose
Paul G Unschuld
Josef Zihl
Elisabeth Binder
Bertram Müller-Myhsok
Florian Holsboer
Susanne Lucae
Max Planck Institute of Psychiatry · DEDr. John T. Macdonald Foundation · USKing's College London · GBCenter for Human Genetics · USHarvard University · USJohns Hopkins University · USUniversity of California, San Francisco · USUNSW Sydney · AU

Funding

Pharmacogenomics of Antidepressant ResponseR01MH072802 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAMILTON, STEVEN P. · 2005 to 2008
$4.6M
TREATMENT RESISTANT DEPRESSION-278990003N01MH090003 · NIMH · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1999 to 2003
–
Medical Research Council G0701420NIMH NIH HHS N01 MH090003NIMH NIH HHS N01MH-90003NIMH NIH HHS R01 MH-072802NIMH NIH HHS R01 MH072802
6 · The paper itself

Abstract

Leptin, a peptide hormone from adipose tissue and key player in weight regulation, has been suggested to be involved in sleep and cognition and to exert antidepressant-like effects, presumably via its action on the HPA-axis and hippocampal function. This led us to investigate whether genetic variants in the leptin gene, the level of leptin mRNA-expression and leptin serum concentrations are associated with response to antidepressant treatment. Our sample consisted of inpatients from the Munich Antidepressant Response Signature (MARS) project with weekly Hamilton Depression ratings, divided into two subsamples. In the exploratory sample (n=251) 17 single nucleotide polymorphisms (SNPs) covering the leptin gene region were genotyped. We found significant associations of several SNPs with impaired antidepressant treatment outcome and impaired cognitive performance after correction for multiple testing. The SNP (rs10487506) showing the highest association with treatment response (p=3.9×10(-5)) was analyzed in the replication sample (n=358) and the association could be verified (p=0.021) with response to tricyclic antidepressants. In an additional meta-analysis combining results from the MARS study with data from the Genome-based Therapeutic Drugs for Depression (GENDEP) and the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) studies, nominal associations of several polymorphisms in the upstream vicinity of rs10487506 with treatment outcome were detected (p=0.001). In addition, we determined leptin mRNA expression in lymphocytes and leptin serum levels in subsamples of the MARS study. Unfavorable treatment outcome was accompanied with decreased leptin mRNA and leptin serum levels. Our results suggest an involvement of leptin in antidepressant action and cognitive function in depression with genetic polymorphisms in the leptin gene, decreased leptin gene expression and leptin deficiency in serum being risk factors for resistance to antidepressant therapy in depressed patients.

Indexed as

Antidepressive AgentsCognitionDatabases, GeneticDepressionDrug ResistanceFemaleGene ExpressionHumansLeptinMaleMiddle AgedPolymorphism, Single NucleotideRNA, MessengerTreatment OutcomeAntidepressive AgentsLeptinRNA, Messenger

Identifiers

PMID23026132
PMCPMC4221661
OpenAlexW2004588635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.